Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Cochran, AJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 65 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lana, AMA; Wen, DR; Cochran, AJ
      The morphology, immunophenotype and distribution of paracortical dendriticleucocytes in lymph nodes regional to cutaneous melanoma

      MELANOMA RESEARCH
    2. Cochran, AJ
      Prudent margins for melanocytic lesions

      EUROPEAN JOURNAL OF PLASTIC SURGERY
    3. Cochran, AJ; Morton, DL; Stern, S; Lana, AMA; Essner, R; Wen, DR
      Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: Implications for tumor biology and treatment

      MODERN PATHOLOGY
    4. Cochran, AJ
      The role of practising pathologists in the generation of novel and original observations

      JOURNAL OF PATHOLOGY
    5. Shen, P; Conforti, AM; Essner, R; Cochran, AJ; Turner, RR; Morton, DL
      Is the node of Cloquet the sentinel node for the iliac/obturator node group?

      CANCER JOURNAL
    6. Cochran, AJ; Essner, R; Rose, DM; Glass, EC
      Principles of sentinel lymph node identification: background and clinical implications

      LANGENBECKS ARCHIVES OF SURGERY
    7. Bechetoille, N; Haftek, M; Staquet, MJ; Cochran, AJ; Schmitt, D; Berthier-Vergnes, O
      Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen typesIV and VII

      MELANOMA RESEARCH
    8. Cochran, AJ; Bhuta, S; Paul, E; Ribas, A
      The shifting patterns of metastatic melanoma

      CLINICS IN LABORATORY MEDICINE
    9. Cochran, AJ; Elashoff, D; Morton, DL; Elashoff, R
      Individualized prognosis for melanoma patients

      HUMAN PATHOLOGY
    10. Cochran, AJ
      Melanoma metastases through the lymphatic system

      SURGICAL CLINICS OF NORTH AMERICA
    11. Cochran, AJ; Balda, BR; Starz, H; Bachter, D; Krag, DN; Cruse, CW; Pijpers, R; Morton, DL
      The Augsburg consensus - Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies

      CANCER
    12. Cochran, AJ
      The pathologist's role in sentinel lymph node evaluation

      SEMINARS IN NUCLEAR MEDICINE
    13. Cochran, AJ
      Untitled - Dr Cochran's reply

      AJCP. American journal of clinical pathology
    14. Cochran, AJ; Wen, DR; Morton, DL
      Surgical pathology of dye-directed selective lymph node dissection

      LYMPHATIC MAPPING AND PROBE APPLICATIONS IN ONCOLOGY
    15. Cochran, AJ
      Cutaneous malignant melanoma of the head and neck: the role of planned definitive surgery - Invited commentary

      EUROPEAN JOURNAL OF PLASTIC SURGERY
    16. Cochran, AJ
      Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    17. Cochran, AJ; Wen, DR; Berthier-Vergnes, O; Bailly, C; Dore, JF; Berard, F; Moulin, G; Thomas, L
      Cytoplasmic accumulation of peanut agglutinin-binding glycoconjugates in the cells of primary melanoma correlates with clinical outcome

      HUMAN PATHOLOGY
    18. Morton, DL; Thompson, JF; Essner, R; Elashoff, R; Stern, SL; Nieweg, OE; Roses, DF; Karakousis, CP; Mozzillo, N; Reintgen, D; Wang, HJ; Glass, EC; Cochran, AJ
      Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma - A multicenter trial

      ANNALS OF SURGERY
    19. Thomas, L; Cochran, AJ
      Diagnosis and management of cutaneous malignant melanoma

      CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE
    20. COCHRAN AJ; BAILLY C; COOK M; CROTTY K; MIHM M; MOOI W; SAGEBIEL R
      RECOMMENDATIONS FOR THE REPORTING OF TISSUES REMOVED AS PART OF THE SURGICAL-TREATMENT OF CUTANEOUS MELANOMA

      Pathology international
    21. GUO J; CHENG L; WEN DR; HUANG RR; COCHRAN AJ
      DETECTION OF TYROSINASE MESSENGER-RNA IN FORMALIN-FIXED, PARAFFIN-EMBEDDED ARCHIVAL SECTIONS OF MELANOMA, USING THE REVERSE-TRANSCRIPTASE IN-SITU POLYMERASE-CHAIN-REACTION

      Diagnostic molecular pathology
    22. BARNHILL RL; PIEPKORN MW; COCHRAN AJ; FLYNN E; KARAOLI T; FOLKMAN J
      TUMOR VASCULARITY, PROLIFERATION, AND APOPTOSIS IN HUMAN-MELANOMA MICROMETASTASES AND MACROMETASTASES

      Modern pathology
    23. COCHRAN AJ; ELASHOFF D; MORTON DL; ELASHOFF R
      INDIVIDUALIZED PROGNOSIS FOR MELANOMA PATIENTS

      Modern pathology
    24. GUO J; HUANG RR; WEN DR; COCHRAN AJ
      DETECTION OF MULTIPLE MELANOMA MARKERS BY THE RT IN-SITU PCR TECHNIQUE

      Modern pathology
    25. HUANG RR; WEN DR; GUO J; GIULIANO AE; TURNER R; NGUYEN M; STERN S; COCHRAN AJ
      MODULATION OF PARACORTICAL DENDRITIC CELLS AND T-LYMPHOCYTES IN BREAST-CANCER SENTINEL NODES

      Journal of leukocyte biology
    26. BARNHILL RL; PIEPKORN MW; COCHRAN AJ; FLYNN E; KARAOLI T; FOLKMAN J
      TUMOR VASCULARITY, PROLIFERATION, AND APOPTOSIS IN HUMAN-MELANOMA MICROMETASTASES AND MACROMETASTASES

      Archives of dermatology
    27. COCHRAN AJ; BAILLY C; COOK M; CROTTY K; MCCARTHY S; MIHM M; MOOI W; SAGEBIEL R
      RECOMMENDATIONS FOR THE REPORTING OF TISSUES REMOVED AS PART OF THE SURGICAL-TREATMENT OF CUTANEOUS MELANOMA

      AJCP. American journal of clinical pathology
    28. LI PX; CHENG L; WEN DR; WISSMANN PB; CHENG J; GRODY WW; COCHRAN AJ
      DEMONSTRATION OF CYTOPLASMIC TYROSINASE MESSENGER-RNA IN TISSUE-CULTURED CELLS BY REVERSE TRANSCRIPTION (RT) IN-SITU POLYMERASE CHAIN-REACTION (PCR) AND RT PCR IN-SITU HYBRIDIZATION

      Diagnostic molecular pathology
    29. COCHRAN AJ; HEENAN P
      THE CLASSIFICATION OF MELANOMA - TIME FOR A FURTHER REVISION

      Melanoma research
    30. FARZAD Z; MCBRIDE WH; OGBECHI H; ASNONGHOLTHOFF C; MORTON DL; COCHRAN AJ
      LYMPHOCYTES FROM LYMPH-NODES AT DIFFERENT DISTANCES FROM HUMAN-MELANOMA VARY IN THEIR CAPACITY TO INHIBIT ENHANCE TUMOR-CELL GROWTH IN-VITRO/

      Melanoma research
    31. DORE JF; MAISONNEUVE P; CATTARUZZA MS; AUTIER P; COCHRAN AJ; BOYLE P
      A MOLECULAR EPIDEMIOLOGIC APPROACH TO THE STUDY OF EXPRESSION OF A METASTASIS MARKER IN PRIMARY MELANOMAS AND ITS CORRELATION WITH INDIVIDUAL PATIENTS RISK OF RECURRENCE OR METASTASIS

      Melanoma research
    32. COCHRAN AJ; BAILLY C; COOK M; CROTTY K; MIHM M; MOOI W; SAGEBIEL R
      RECOMMENDATIONS FOR THE REPORTING OF TISSUES REMOVED AS PART OF THE SURGICAL-TREATMENT OF CUTANEOUS MELANOMA

      Virchows Archiv
    33. COCHRAN AJ
      PREDICTION OF OUTCOME FOR PATIENTS WITH CUTANEOUS MELANOMA

      Pigment cell research
    34. COCHRAN AJ
      PROPOSED RECLASSIFICATION OF MELANOMA - A MEETING HELD AT THE 16TH INTERNATIONAL PIGMENT CELL CONGRESS, 3-NOVEMBER-1996

      Pigment cell research
    35. COCHRAN AJ; BROWN H
      LIVING AND WORKING IN THE SUN - A SYMPOSIUM HELD AS PART OF THE 16TH INTERNATIONAL PIGMENT CELL CONFERENCE

      Pigment cell research
    36. COCHRAN AJ; BAILLY C; MIHM M; MOOI W; SAGEBIEL R
      RECOMMENDATIONS FOR THE REPORTING OF TISSUES REMOVED AS PART OF THE SURGICAL-TREATMENT OF CUTANEOUS MELANOMA

      Modern pathology
    37. COCHRAN AJ; BAILLY C; COOK M; CROTTY K; MIHM M; MOOI W; SAGEBIEL R
      RECOMMENDATIONS FOR THE REPORTING OF TISSUES REMOVED AS PART OF THE SURGICAL-TREATMENT OF CUTANEOUS MELANOMA

      Human pathology
    38. GUO J; CHENG L; WEN DR; HUANG RR; GRODY W; COCHRAN AJ
      TYROSINASE MESSENGER-RNA DEMONSTRATED IN FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUES, USING THE IN-SITU REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION

      Laboratory investigation
    39. WEN DR; MORTON DL; COCHRAN AJ
      THE PATHOLOGY OF MELANOMA PATIENTS WITH NEGATIVE SENTINEL NODES WHO SUBSEQUENTLY DEVELOP IPSILATERAL NODAL METASTASES

      Laboratory investigation
    40. CARSON KF; WEN DR; LI PX; LANA AMA; BAILLY C; MORTON DL; COCHRAN AJ
      NODAL NEVI AND CUTANEOUS MELANOMAS

      The American journal of surgical pathology
    41. COCHRAN AJ; MORTON DL; GUO J; BHUTA S; KASRAVI B; LANA AMA; LIE L; WEN DR
      SUPPRESSION OF ANTIGEN-PRESENTING CELLS IN (SENTINEL) LYMPH-NODES CLOSE TO MALIGNANT-MELANOMA CORRELATES WITH EARLY METASTASES

      Laboratory investigation
    42. THOMAS L; COCHRAN AJ; BERTHIERVERGNES O; WEN DR; BERARD F; MOULIN G
      EXPRESSION OF PEANUT AGGLUTININ-BINDING GLYCOCONJUGATES IS CORRELATEDWITH HISTOPROGNOSIS AND REAL PROGNOSIS IN PRIMARY CUTANEOUS MELANOMA

      Journal of investigative dermatology
    43. COCHRAN AJ
      DYSPLASTIC NEVI - REPLY

      Histopathology
    44. LI PX; CHENG L; WEN DR; CHENG J; WISSMANN PB; GRODY W; COCHRAN AJ
      DETECTION OF CYTOPLASMIC TYROSINASE MESSENGER-RNA BY REVERSE-TRANSCRIPTASE PCR IN-SITU HYBRIDIZATION (RT-PCR ISH) IDENTIFIES CELLS OF MELANOCYTIC LINEAGE

      Laboratory investigation
    45. ZEBDA N; THOMAS L; DORE JF; COCHRAN AJ; BERTHIERVERGNES O
      SELECTIVE EXPRESSION OF PNA-RECOGNIZED GLYCOPROTEINS BY METASTATIC HUMAN-MELANOMA CELLS

      Journal of investigative dermatology
    46. BUSAM KJ; BERWICK M; BLESSING K; FANDREY K; KANG S; KARAOLI T; FINE J; COCHRAN AJ; WHITE WL; RIVERS J; ELDER DE; WEN DRP; HEYMAN BH; BARNHILL RL
      TUMOR VASCULARITY IS NOT A PROGNOSTIC FACTOR FOR MALIGNANT-MELANOMA OF THE SKIN

      The American journal of pathology
    47. DORE JF; BERTHIERVERGNES O; ZEBDA N; BAILLY M; THOMAS L; BAILLY C; COCHRAN AJ
      SELECTIVE EXPRESSION OF PNA-BINDING GLYCOCONJUGATES BY INVASIVE HUMANMELANOMAS - A NEW MARKER OF METASTATIC POTENTIAL

      Pigment cell research
    48. COCHRAN AJ
      15TH INTERNATIONAL PIGMENT CELL CONFERENCE - A MEETING FOR ALL SEASONS - POSTSCRIPT

      Pigment cell research
    49. COCHRAN AJ
      THE ROLE OF THE HISTOPATHOLOGIST IN THE DIAGNOSIS OF DYSPLASTIC NEVI

      Histopathology
    50. BARNHILL RL; BUSAM KJ; BERWICK M; BLESSING K; COCHRAN AJ; ELDER DE; FANDREY K; KARAOLI T; WHITE WL
      TUMOR VASCULARITY IS NOT A PROGNOSTIC FACTOR FOR CUTANEOUS MELANOMA

      Lancet
    51. ALALOUSI S; CARLSON JA; BLESSING K; COOK MG; COCHRAN AJ; WEN DR; BARNHILL RL
      THE IN-VIVO EXPRESSION OF BASIC FIBROBLASTIC GROWTH-FACTOR IN CUTANEOUS MELANOMA - IMPLICATIONS FOR DESMOPLASIA AND ANGIOGENESIS

      Laboratory investigation
    52. CARSON K; WEN DR; LI PX; COCHRAN AJ
      NODAL NEVI ARE FREQUENT AND SELECTIVELY LOCATED IN MELANOMA-DRAINING NODES - IMPLICATIONS FOR THEIR ETIOLOGY

      Laboratory investigation
    53. WANEK LA; ELASHOFF RM; GORADIA TM; MORTON DL; COCHRAN AJ
      APPLICATION OF MULTISTAGE MARKOV MODELING TO MALIGNANT-MELANOMA PROGRESSION

      Cancer
    54. LITMAN DA; COCHRAN AJ; HIRSHOWITZ SL
      FALSE-POSITIVE HMB-45 STAINING OF AXILLARY APOCRINE CELLS

      Acta cytologica
    55. COCHRAN AJ; LU HF; LI PX; SAXTON R; WEN DR
      S-100 PROTEIN REMAINS A PRACTICAL MARKER FOR MELANOCYTIC AND OTHER TUMORS

      Melanoma research
    56. COCHRAN AJ
      MALIGNANT-MELANOMA - INTRODUCTION

      Seminars in diagnostic pathology
    57. COCHRAN AJ; BAILLY C; PAUL E; DOLBEAU D
      NEVI, OTHER THAN DYSPLASTIC AND SPITZ NEVI

      Seminars in diagnostic pathology
    58. BINDER SW; ASNONG C; PAUL E; COCHRAN AJ
      THE HISTOLOGY AND DIFFERENTIAL-DIAGNOSIS OF SPITZ NEVUS

      Seminars in diagnostic pathology
    59. ROBERT ME; WEN DR; COCHRAN AJ
      PATHOLOGICAL EVALUATION OF THE REGIONAL LYMPH-NODES IN MALIGNANT-MELANOMA

      Seminars in diagnostic pathology
    60. HAYS JT; MAHMARIAN JJ; COCHRAN AJ; VERANI MS
      DOBUTAMINE TL-201 TOMOGRAPHY FOR EVALUATING PATIENTS WITH SUSPECTED CORONARY-ARTERY DISEASE UNABLE TO UNDERGO EXERCISE OR VASODILATOR PHARMACOLOGICAL STRESS-TESTING

      Journal of the American College of Cardiology
    61. BERTHIERVERGNES O; ZEBDA N; BAILLY M; BROWN S; DORE JF; COCHRAN AJ
      UNSIALYLATED PNA BINDING-SITES IN HUMAN-MELANOMA - A NEW MARKER OF METASTATIC POTENTIAL

      Glycoconjugate journal
    62. MAHMARIAN JJ; COCHRAN AJ; MARKS GF; VERANI MS
      MODELS FOR PREDICTING LONG-TERM OUTCOME AFTER ACUTE MYOCARDIAL-INFARCTION BY QUANTITATIVE ADENOSINE TOMOGRAPHY

      The Journal of nuclear medicine
    63. BERTHIERVERGNES O; ZEBDA N; BAILLY M; BAILLY C; DORE JF; THOMAS L; COCHRAN AJ
      EXPRESSION OF PEANUT AGGLUTININ-BINDING GLYCOCONJUGATES IN PRIMARY MELANOMAS WITH HIGH-RISK OF METASTASES

      Lancet
    64. LONGIN A; BERGERDUTRIEUX N; FONTANIERE B; COCHRAN AJ; DEVONEC M; DOLBEAU D; GUILLAUD M; LAURENT JC
      STUDIES OF MONOCLONAL-ANTIBODY BL2-10D1 AS A MARKER FOR THE DETECTIONOF THE UROTHELIAL ORIGIN OF TUMORS

      Cancer
    65. MORTON DL; DAVTYAN DG; WANEK LA; FOSHAG LJ; COCHRAN AJ
      MULTIVARIATE-ANALYSIS OF THE RELATIONSHIP BETWEEN SURVIVAL AND THE MICROSTAGE OF PRIMARY MELANOMA BY CLARK LEVEL AND BRESLOW THICKNESS

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 23:27:44